Eduardo Yepez Guevara, M.D., FACP
Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Fellowship Program Associate Director, Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2006 | Universidad Nacional de Trujillo, Trujillo, PE, Medicine, MD |
Postgraduate Training
| 2018-2019 | Clinical Fellowship, Transplantation Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, Texas |
| 2016-2018 | Clinical Fellowship, Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, Texas |
| 2011-2013 | Clinical Residency, Internal Medicine, New York Medical College - Metropolitan Hospital, New York, New York |
| 2010-2011 | Clinical Internship, Internal Medicine, New York Medical College - Metropolitan Hospital, New York, New York |
| 2008-2010 | House Physician in Clinical Immunology, University of Miami - Jackson Memorial Hospital, Miami, Florida |
Board Certifications
| 2018 | American Board of Internal Medicine - Infectious Disease |
| 2013 | American Board of Internal Medicine - Internal Medicine, Longitudinal Knowledge Assessment |
Experience & Service
Academic Appointments
Assistant Professor, Department of General Internal Medicine, New York Medical College - Metropolitan Hospital, New York, New York, 2013 - 2016
Administrative Appointments/Responsibilities
Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Associate Program Director, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present
Associate Program Director, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present
Core Faculty- Infectious Diseases Fellowship, Department of Infectious Diseases, Baylor College of Medicine, Houston, Texas, 2022 - Present
Core Faculty- Infectious Diseases Fellowship, Department of Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, Texas, 2022 - Present
EPIC Super User, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2021 - Present
Associate Medical Director, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - Present
Chief Clinical Fellow in Infectious Diseases, Department of Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, Texas, 2017 - 2018
Assistant Chief Medical Resident, Department of General Internal Medicine, New York Medical College - Metropolitan Hospital, New York, New York, 2012 - 2013
Other Appointments/Responsibilities
Cooperative Service - Texas Viral Hepatitis Elimination Summit, Infectious Diseases, Texas Department of State Health Services, Houston, Texas, 2023 - 2023
Consultant / Panelist - Infections in the Hematopoietic Cell Transplantation Setting: Improving Outcomes Through Interdisciplinary Care (Web Based CME Activity), Terranova Medica and Society of Infectious Diseases Pharmacists Education Center (SIDPEC), 2020 - 2021
Institutional Committee Activities
Trainee Lead, Hepatitis C Special Interest Group AASLD, 2025 - 2026
Member, International ECHO Sessions on Viral Hepatitis in Patients with Cancer, 2023 - Present
Member, Graduate Medical Education Committee, 2022 - Present
Lead for the Educate the Educator working group, Division of Internal Medicine Education Committee, 2022 - Present
Member, Pharmacy & Therapeutics Committee, 2021 - Present
Associate Medical Director, Antimicrobial Stewardship Team, 2020 - Present
Member, Clinical Competence Committee, 2013 - 2016
Honors & Awards
| House Physician Award, University of Miami - Jackson Memorial Hospital | |
| Most Outstanding PGY1, New York Medical College - Metropolitan Hospital | |
| Most Outstanding Clinical Preceptor, New York Medical College - Metropolitan Hospital | |
| Trainee Travel Grant Award, Infectious Diseases Society of America | |
| Fellow Scholarship Award, Remington Winter Course in Infectious Diseases | |
| Second Place Clinical Research - Poster Session Award, Division of Internal Medicine Research Retreat - MD Anderson Cancer Center | |
| Fellow of the American College of Physicians, American College of Physicians | |
| Awesome Job Award, MD Anderson Infectious Diseases APPs |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Torres HA, Mustafayev K, Juneau R, Hwang JP, Wang LS, Angelidakis G, Hawk E, Granwehr BP, Yepez Guevara E, Ying AK. Implementation of Universal Hepatitis C Virus Screening in a Tertiary Care Cancer Center. JNCCN 22(2D), 2024. e-Pub 2023. PMID: 38729204.
- Alexander Franklin, Teny M John, Fareed Khawaja, Ying Jiang, Yepez Guevara E, Jitesh Ahuja, Saadia A Faiz, Lara Bashoura, Ajay Sheshadri, Vickie R Shannon, Diwakar D Balachandran, Kelly McConn, Victor E Mulanovich, Micah Bhatti, Roy F Chemaly. Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients With Cancer. J Infect Dis None(None):None, 2023. PMID: 37983000.
- Yibirin M, Mustafayev K, Hosry J, Pundhir P, Klingen J, Yepez Guevara E, Granwehr BP, Kaseb A, Naing A, Patel S, Shah AY, Skoulidis F, Tawbi HA, Wang L, Miller E, Zhang HC, Zurita-Saavedra A, Torres HA. Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients with Solid Tumors. Am J Gastroenterol 118(9):1609-1617, 2023. e-Pub 2023. PMID: 37307533.
- Dagher H, Chaftari AM, Subbiah IM, Malek AE, Jiang Y, Lamie P, Granwehr B, John T, Yepez E, Borjan J, Reyes-Gibby C, Flores M, Khawaja F, Pande M, Ali N, Rojo R, Karp DD, Chaftari P, Hachem R, Raad II. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. Elife 12, 2023. e-Pub 2023. PMID: 36748905.
- Raad, II, Hachem, RY, Masayuki, N, Datoguia, TS, Dagher, H, Jiang, Y, Subbiah, V, Siddiqui, B, Bayle, A, Somer, RA, Fernández-Cruz, A, Gorak, E, Bhinder, A, Mori, N, Hamerschlak, N, Shelanski, S, Dragivich, T, Kiat, YV, Fakhreddine, S, Hanna, PA, Chemaly, RF, Mulanovich, VE, Adachi, JA, Borjan, J, Khawaja, F, Granwehr, BP, John, TM, Yepez Guevara, E, Torres, HA, Ammakkanavar, NR, Yibirin, M, Reyes-Gibby, CC, Pande, M, Ali, N, Rojo, RD, Ali, S, Deeba, R, Chaftari, P, Matsuo, T, Ishikawa, K, Hasegawa, R, Aguado-Noya, R, García, ÁG, Puchol, CT, Lee, DG, Slavin, MA, Teh, B, Arias, CA, Kontoyiannis, DP, Chaftari, AP. International Multicenter Study Comparing COVID-19 in Patients With Cancer to Patients Without Cancer: impact of Risk Factors and Treatment Modalities on Survivorship. ELife 12, 2023. PMID: 36715684.
- Francisco, D, Zhang, L, Jiang, Y, Olvera, AV, Adachi, JA, Yepez Guevara, E, Aitken, SL, Garey, K, Peterson, CB, Do, K, Dillon, R, Obi, EN, Jenq, RR, Okhuysen, PC. Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer. Infectious Diseases and Therapy 12(1):209-225, 2023. PMID: 36443547.
- Ariel D Szvalb MD, Eduardo Yepez Guevara MD, Elizabeth Euscher MD, MD PhD KAN, Dimitrios P Kontoyiannis MD. Acute Peritoneal Histoplasmosis Mimicking Ovarian Cancer and Review of the Literature on Histoplasma Peritonitis. Open Forum Infectious Diseases 10(1):None, 2023. e-Pub 2023. PMID: 36686636.
- Yibirin M, Hosry J, Yepez Guevara E, Granwehr BP, Jiang Y, Mustafayev K, Angelidakis G, Torres HA. High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virus. Eur J Gastroenterol Hepatol 34(10):1098-1101, 2022. e-Pub 2022. PMID: 36062500.
- Yepez Guevara EA, Aitken SL, Olvera AV, Carlin L, Fernandes KE, Bhatti MM, Garey KW, Adachi J, Okhuysen PC. Clostridioides difficile infection in cancer and immunocompromised patients: Relevance of a two-step diagnostic algorithm and infecting ribotypes on clinical outcomes. Clin Infect Dis 72(10):e460-e465, 2021. e-Pub 2020. PMID: 32803229.
- Mohammed Samannodi, Vaghefi-Hosseini R, Nigo M, Guevara EY, Hasbun R. Risk Classification for Respiratory Viral Infections in Adult Solid Organ Transplantation Recipients. Transplantation Proceedings 53(2):737-742, 2020. e-Pub 2020. PMID: 33272649.
Manuals, Teaching Aids, Other Teaching Publications
- Carolyn Alonso, Vasilios Athans, Dayna McManus, Jennifer L. Saullo, Frank Tverdek, Yepez Guevara E. Infections in the Hematopoietic Cell Transplantation Setting: Improving Outcomes Through Interdisciplinary Care - Web CME Activity. Terranova Medica and Society of Infectious Diseases Pharmacists Education Center (SIDPEC), 2020.
Other Articles
- Galarreta CI, Yepez E, Velez C, Aita G [Primary T cell lymphoma of the pancreas: clinical case report]. Rev Gastroenterol Peru 32(4):423-8, 2012. PMID: 23307095.
Abstracts
- Mustafayev K, Naing A, Thomas SK, Patel KK, Pemmaraju N, Daver NG, Jiang Y, Yepez Guevara E, Torres HA. Treatment of Chronic Hepatitis C Virus Infection To Increase Access To Cancer Clinical Trials In Patients With Hematologic Malignancies: A Prospective Observational Study. Journal of Clinical Oncology 41(16):3142-3142, 2023. PMID: None.
- Francisco D, Olvera A, Jiang Y, Zhang L, Guevara EY, Garey KW, Peterson C, Kim-Anh, Dillon R, Obi EN, Jenq R, Okhuysen PC. Metronidazole Exposure Prior to Clostridiodes difficile Infection (CDI) is a Risk Factor for Severe C. difficile Disease in Cancer Patients. Open Forum Infect Dis None(None):None, 2020. PMID: None.
- Olvera A, Yepez Guevara E, Garey K, Dillon R, Okhuysen P. Fecal Biomarkers for Clostridioides difficile Infection in Cancer Patients. Open Forum Infectious Diseases 6(Suppl 2):S763-S764, 2019. e-Pub 2019. PMID: None.
- Francisco DM, Olvera A, Zhang L, Yepez Guevara E, Garey K, Peterson C, Do K, Dillon R, Jenq R, Okhuysen P. Fecal Collinsella Abundance is Negatively Associated with Toxin A/B Production in Cancer Patients with Clostridioides difficile. Open Forum Infect Dis 6(Suppl 2):S821–S822, 2019. e-Pub 2019. PMID: None.
- Andrew C, Harika Y, Eduardo YG, Micah B, Samuel A, Pablo O. Line of Service – Specific Performance and Antibiotic Prescribing Habits Following Introduction of a Two-Step Diagnostic Approach Using NAAT Followed by Enzyme Immunoassay in Cancer Patients with Suspected Clostridium difficile Infection. Open Forum Infectious Diseases 4(Suppl 1):S394, 2017. e-Pub 2017. PMID: None.
- Yepez E, Yalamanchili H, Chao A, Garey K, Bhatti M, Aitken S, Okhuysen P. Ribotypes matter. Significance of Clostridium difficile ribotypes in Cancer patients with diarrhea. Open Forum Infectious Diseases 4(Suppl 1):S386–S387, 2017. e-Pub 2017. PMID: None.
- Harika Y, Andrew C, Eduardo YG, Samuel A, Micah B, Pablo O. Risk Factors and Clinical Outcomes of Cancer Patients with Clostridium difficile Associated Diarrhea Co-infected with a Second Enteropathogen. Open Forum Infect Dis 4(Suppl 1):S362–S363, 2017. e-Pub 2017. PMID: None.
Book Chapters
- Yepez Guevara, E, Abdel Rahman, Z, Daher, M, Mulanovich, VE. Management of Infections in Stem Cell Transplant Recipients. In: Manual of Stem Cell Transplantation and Cellular Therapies for Hematologic Malignancies. ELSEVIER, 429-442, 2023.
- Yepez E, Banchs J, Tweardy D, Adachi J. Infectious Endocarditis in Cancer patients. In: Cancer and the Heart. 3. People’s Medical Publishing House, 477-489, 2019.
Letters to the Editor
- Mustafayev K, Yepez Guevara E, DiNardo CD, Jabbour E, Ghayas IC, Ratan R, Pemmaraju N, Torres HA. Virologic effect and hepatotoxicity of BCR::ABL1 tyrosine kinase inhibitors in cancer patients with chronic hepatitis C virus infection: A prospective study. Leuk Res 147: 107597, 2024.
- Chiu, CY, Mustafayev, K, Lee, HC, Manasanch, EE, Yepez Guevara, E, Torres, HA. Effect of anti-CD38 monoclonal antibodies on hepatitis C virus replication in chronically infected patients with multiple myeloma a prospective series. Leukemia and Lymphoma 64: 900-903, 2023.
- Pundhir, P, Roach, LR, Bartek, J, Trask, RP, Yibirin, M, Yepez Guevara, E, Granwehr, BP, Swalwell, CR, Torres, HA. Nursing practice is associated with high risk for hepatitis C virus infection. Clinical Microbiology and Infection 27: 1362-1364, 2021.
Patient Reviews
CV information above last modified December 11, 2024